Drug and Device Development Outsourcing 2.0 - Soaring Beyond the CRO

January 9, 2023

ProPharma Group - the end-to-end, global provider of regulatory, clinical and compliance services for the pharmaceutical, biotechnology and medical device industries launched the Research Consulting Organization (RCO) model, a new type of research consulting and clinical service for biotech, pharma and device innovators to deliver bespoke solutions that bring life-saving drugs to market sooner and more cost effectively.


 

Download the Whitepaper

TAGS:

Brian Katz, Chief Strategy Officer (CSO) / Head of Corporate Development

September 13, 2022

ProPharma announces the appointment of Bryan Katz as new Chief Strategy Officer (CSO) / Head of Corporate Development

ProPharma Group (PPG), a portfolio company of Odyssey Investment Partners, announces the expansion of the senior leadership team to include Bryan Katz as the new Chief Strategy Officer (CSO) / Head...

May 31, 2012

ProPharma Group named Ingram's Best Company to Work For 2012!

ProPharma Group has been chosen by Ingram's Magazine as one of their Best Companies to Work For! Read what Ingram's has to say about us. There are carts. And there are horses. Jeff Hargroves can tell...

Hands working on a laptop

September 1, 2022

ProPharma Group Announces Acquisition of Kateric, An Industry-Leading Medical Writing Company

Chicago, IL, September 1, 2022 -- ProPharma Group (PPG), the leading global provider of regulatory, clinical and quality services for the life sciences industry, announces the acquisition of Kateric...